4512.T
WAKAMOTO PHARMACEUTICAL CO.,LTD.
スタンダード · 医薬品 · 医薬品 · JP
JPY 300.00
+0.00%Year over year
Reported trailing growth
- Revenue
- +16.8%
- EBITDA
- —
- EBIT
- +125.6%
- EPS
- +1.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +7.6%
- EBITDA
- —
- EPS
- -32.9%
Three-year CAGR
- Revenue
- -2.4%
- EBITDA
- —
- EBIT
- —
- Net income
- -35.5%
- EPS
- -35.4%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026